No analyst coverage available for this stock.
Bellevue Group AG is a Switzerland-based, independent asset management firm founded in 1993 and headquartered in Zurich. It specializes as a pure-play asset manager with a distinctive focus on healthcare investments, including biotech, medtech, thematic strategies, and global and regional healthcare funds, which represent around 89% of its client assets. The company also offers solutions for small and mid-sized entrepreneur investments, such as listed small and mid caps and private equity strategies through its Bellevue Private Markets division, alongside multi-asset, bonds, and alternatives. Operating primarily through subsidiaries like Bellevue Asset Management and StarCapital, it serves institutional, intermediary, and private clients across Switzerland, Germany, the United Kingdom, and internationally. With approximately 90 employees and CHF 5.8 billion in assets under management as of 2024, Bellevue Group AG emphasizes innovation, such as funds targeting obesity solutions and AI in healthcare, positioning it as a key player in specialized growth sectors within the financial markets.